Community Outreach

Certain medications increase the risk of hyperkalemia, requiring careful monitoring. ACE inhibitors, ARBs, potassium-sparing diuretics, NSAIDs, and some beta-blockers can elevate potassium levels. Clinicians manage medication-induced hyperkalemia by adjusting doses, switching drugs, or introducing potassium-lowering treatments.

Regular blood testing ensures that potassium remains within safe limits. Patients with kidney impairment are particularly vulnerable, highlighting the importance of individualized treatment plans. Combining medication review with pharmacological therapy and lifestyle adjustments provides a comprehensive approach to prevention and treatment.